戻る
Burning Rock Biotech Ltd (BNR) 収入
BNR 株価推移チャート
BNR 収入
Burning Rock Biotech Ltd
$20.5
3.48%
$0.69
終値： Mar 25, 16:00:00 GMT-4
$20.5
0%
$0
アフターマーケット：Mar 25, 20:00:00 GMT-4
最新の利益結果: Q3 '22
報告済み: 2022-11-15
歴史的収益
四半期
年次
EPS
収入
Earnings FAQ
BNRの最近の1株当たり利益（EPS）は予想と比較してどうでしたか？
Burning Rock Biotech Ltd BNRの前四半期の収益はどうでしたか？
Burning Rock Biotech Ltdの収益見積もりはいくらですか？
Burning Rock Biotech Ltdの収益品質スコアはどれくらいですか？
Burning Rock Biotech Ltdはいつ収益を報告しますか？
Burning Rock Biotech Ltdの予想収益はいくらですか？
Burning Rock Biotech Ltdは収益予想を上回りましたか？
主要データ
前終値
$19.81
始値
$19.85
当日レンジ
$19.85 - $20.5
52週レンジ
$2.18 - $41.72
取引高
134.3K
平均取引高
24.1K
配当利回り
--
1株当たり利益(TTM)
-1.16
時価総額
$210.3M
BNRとは何ですか？
Burning Rock Biotech Ltd. engages in the investment of medical fields. The company is headquartered in Guangzhou, Guangdong and currently employs 674 full-time employees. The company went IPO on 2020-06-12. The firm operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.